ALB and Miyoshi myopathy: In summary, the anti-MM activities of composite 3NPs, As4S4/ZnS/Fe3O4 (1:4:1), As4S4/ZnS/Fe3O4 with FA, and As4S4/ZnS/Fe3O4 with FA and Alb, were confirmed by the decreased survival of MM cell lines and primary patient-derived MM cells and by higher anti-MM activities in combination with lenalidomide, pomalidomide, or melphalan.